A Canadian biopharmaceutical company and a Belgian nonprofit will collaborate to develop a treatment for cervical cancer, HealthWire reported July 4.
Helix Biopharma Inc. is preparing for clinical trials for a new medicated cream called Biphasix with the help of the Althea Foundation. The foundation was established in 1995 to advance medical and pharmaceutical research.
In preparation for the trials, Helix has appointed Dr. Denny DiPetrillo and Dr. Gordon Lickrish to its medical advisory boards. Both are internationally known gynecological oncologists who work at the University of Toronto.
For full text, see Altavista.